Funds holding BioNTech SE
ISIN US09075V1026 · Germany · LEI 894500UZJ5LG1F8J1U58
- Fund holders
- 162
- Of which ETFs
- 30 132 other funds
- Value held
- 2B $ 287.9M SEK · 1.1M €
162 funds hold this company. This table lists the 157 that declare it in a regulatory filing. The other 5 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 5,726 | 631.2K $ | 0.83 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 5,616 | 499.2K $ | 1.27 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Innovate Equity ETF Goldman Sachs ETF Trust | 5,162 | 569K $ | 0.27 % | as of Feb 28, 2026 ↗ |
| BNY Mellon International Equity ETF BNY Mellon ETF Trust | 4,903 | 510.4K $ | 0.04 % | as of Apr 30, 2026 ↗ |
| Calvert International Responsible Index Fund Calvert Responsible Index Series, Inc. | 4,826 | 428.9K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 4,669 | 514.7K $ | 0.56 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs MarketBeta International Equity ETF Goldman Sachs ETF Trust | 4,543 | 501K $ | 0.05 % | as of Feb 28, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 4,340 | 385.7K $ | 1.80 % | as of Mar 31, 2026 ↗ |
| Lysa Global Equity Focus Lysa Fonder AB | 4,035 | 3.4M SEK | 0.06 % | as of Mar 31, 2026 ↗ |
| BlackRock Balanced Fund, Inc. BlackRock Balanced Fund, Inc. | 4,028 | 444K $ | 0.03 % | as of Feb 27, 2026 ↗ |
| Capital Appreciation Portfolio PACIFIC SELECT FUND | 3,821 | 339.6K $ | 0.33 % | as of Mar 31, 2026 ↗ |
| PROFUND VP EUROPE 30 ProFunds | 3,450 | 306.6K $ | 1.93 % | as of Mar 31, 2026 ↗ |
| VIP International Index Portfolio Variable Insurance Products Fund II | 3,438 | 305.6K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Value K6 Fund Fidelity Devonshire Trust | 3,126 | 323.4K $ | 0.27 % | as of Apr 30, 2026 ↗ |
| Lysa Global Equity Broad Lysa Fonder AB | 2,954 | 2.5M SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| BlackRock Tactical Opportunities Fund BlackRock Funds | 2,892 | 299.2K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Franklin Allocation VIP Fund Franklin Templeton Variable Insurance Products Trust | 2,600 | 231.1K $ | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Balanced K6 Fund Fidelity Puritan Trust | 2,589 | 285.4K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 2,544 | 226.1K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 2,296 | 253.1K $ | 0.42 % | as of Feb 28, 2026 ↗ |
| Fidelity Climate Action Fund Fidelity Summer Street Trust | 2,280 | 251.3K $ | 0.53 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1,829 | 162.6K $ | 0.80 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Mid Cap Value Portfolio SEASONS SERIES TRUST | 1,825 | 162.2K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MarketBeta Total International Equity ETF Goldman Sachs ETF Trust II | 1,545 | 170.4K $ | 0.03 % | as of Feb 27, 2026 ↗ |
| NYLI Candriam International Equity ETF New York Life Investments ETF Trust | 1,440 | 149.9K $ | 0.06 % | as of Apr 30, 2026 ↗ |
| ALGER RESPONSIBLE INVESTING FUND ALGER FUNDS II | 1,407 | 145.6K $ | 0.11 % | as of Apr 30, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 1,381 | 122.7K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Länsförsäkringar Globala Mål Index Länsförsäkringar Fondförvaltning AB | 1,369 | 1.1M SEK | 0.04 % | as of Mar 31, 2026 ↗ |
| PIMCO RAE International Fund PIMCO Equity Series | 1,353 | 120.3K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| BlackRock Balanced Portfolio BlackRock Series Fund, Inc. | 1,317 | 117.1K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 1,289 | 114.6K $ | 0.60 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Variable Trust | 1,288 | 114.5K $ | 1.07 % | as of Mar 31, 2026 ↗ |
| Langar Global Health Tech ETF SPINNAKER ETF SERIES | 1,282 | 113.9K $ | 3.28 % | as of Mar 31, 2026 ↗ |
| SA PIMCO RAE International Value Portfolio SUNAMERICA SERIES TRUST | 1,260 | 130.3K $ | 0.03 % | as of Apr 30, 2026 ↗ |
| EUROPE 30 PROFUND ProFunds | 1,168 | 120.8K $ | 2.10 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 1,108 | 98.5K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| JNL/Mellon World Index Fund JNL Series Trust | 1,072 | 95.3K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Calvert International Responsible Index ETF Morgan Stanley ETF Trust | 1,056 | 93.9K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund FlexShares Trust | 1,024 | 105.9K $ | 0.02 % | as of Apr 30, 2026 ↗ |
| Global Atlantic BlackRock Disciplined Core Portfolio Forethought Variable Insurance Trust | 1,008 | 89.6K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex International Focused Index Fund Fidelity Salem Street Trust | 801 | 82.9K $ | 0.07 % | as of Apr 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 700 | 77.2K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 675 | 60K $ | 0.48 % | as of Mar 31, 2026 ↗ |
| Invesco Income Advantage U.S. Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 670 | 73.9K $ | 0.04 % | as of Feb 28, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 533 | 47.4K $ | 2.09 % | as of Mar 31, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 507 | 52.4K $ | 0.52 % | as of Apr 30, 2026 ↗ |
| JNL/JPMorgan Global Allocation Fund JNL Series Trust | 397 | 35.3K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| MFS Global Alternative Strategy Fund MFS Series Trust XV | 257 | 26.6K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| E*TRADE No Fee International Index Fund E Trade Trust | 234 | 24.4K $ | 0.04 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Global Index Core Handelsbanken Fonder AB | 217 | 180.8K SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| SA JPMorgan Diversified Balanced Portfolio SUNAMERICA SERIES TRUST | 173 | 17.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 47 | 4.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| WAM HIGH CONVICTION, FI WELCOME ASSET MANAGEMENT, SGIIC, S.A. | 510.6K € | 1.57 % | as of Dec 31, 2025 ↗ | |
| ARBITRAGE CAPITAL, SICAV, S.A. RENTA 4 GESTORA, S.G.I.I.C., S.A. | 244.1K € | 0.27 % | as of Dec 31, 2025 ↗ | |
| KOALA CAPITAL SICAV, S.A. GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 218.8K € | 0.92 % | as of Dec 31, 2025 ↗ | |
| EKO INVESTMENT CAPITAL SICAV SA SINGULAR ASSET MANAGEMENT, SGIIC, S.A. | 97.3K € | 0.34 % | as of Dec 31, 2025 ↗ | |
| MERCH-EUROUNION, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 72.9K € | 1.62 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 3.87 % | as of Feb 28, 2026 ↗ |
| Langar Global Health Tech ETF SPINNAKER ETF SERIES | 3.28 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.16 % | as of Mar 31, 2026 ↗ |
| Echiquier Health Impact for All La Financière de l'Échiquier | 2.55 % | as of Jun 30, 2025 ↗ |
| Echiquier World Equity Growth La Financière de l'Échiquier | 2.23 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 2.15 % | as of Mar 31, 2026 ↗ |
| EUROPE 30 PROFUND ProFunds | 2.10 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 2.09 % | as of Mar 31, 2026 ↗ |
| PROFUND VP EUROPE 30 ProFunds | 1.93 % | as of Mar 31, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 1.80 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 141 | +6 | 21,055,737 | +10.9 % |
| 2026Q1 | 135 | -18 | 18,986,471 | -4.0 % |
| 2025Q4 | 153 | -14 | 19,772,784 | +19.0 % |
| 2025Q3 | 167 | +11 | 16,611,285 | +6.6 % |
| 2025Q2 | 156 | -4 | 15,579,722 | +6.1 % |
| 2025Q1 | 160 | +37 | 14,679,590 | +20.3 % |
| 2024Q4 | 123 | +28 | 12,197,517 | +23.4 % |
| 2024Q3 | 95 | +12 | 9,883,719 | -4.6 % |
| 2024Q2 | 83 | 0 | 10,361,530 | +0.2 % |
| 2024Q1 | 83 | -5 | 10,340,942 | +2.0 % |
| 2023Q4 | 88 | 10,136,650 |
Institutional managers
271 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5,856,073 | 520.5K $ | as of Mar 31, 2026 |
| FMR LLC | 5,709,240 | 507.4M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 3,793,711 | 337.2M $ | as of Mar 31, 2026 |
| FLOSSBACH VON STORCH SE | 3,680,315 | 327.1M $ | as of Mar 31, 2026 |
| Dodge & Cox | 3,676,791 | 326.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,658,153 | 147.4M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 1,651,789 | 146.8M $ | as of Mar 31, 2026 |
| Temasek Holdings (Private) Ltd | 1,506,027 | 133.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 951,372 | 84.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 903,029 | 80.3M $ | as of Mar 31, 2026 |
| GSK plc | 889,824 | 79.1M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 882,572 | 78.4M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 839,991 | 74.7M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 783,995 | 69.7M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 670,514 | 59.6M $ | as of Mar 31, 2026 |
| Long Focus Capital Management, LLC | 624,000 | 55.5M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 488,367 | 43.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 482,411 | 42.9M $ | as of Mar 31, 2026 |
| DekaBank Deutsche Girozentrale | 481,397 | 42.1K $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 476,923 | 42.4M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 470,000 | 41.8M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 391,689 | 34.8M $ | as of Mar 31, 2026 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 387,214 | 34.4M $ | as of Mar 31, 2026 |
| LBP AM SA | 385,109 | 34.2M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 384,626 | 34.2M $ | as of Mar 31, 2026 |
Declared shareholders of BioNTech SE
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| ATHOS KG and 2 others | 40.20 % | 101,702,378 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding BioNTech SE". https://titelia.com/en/stocks/biontech-se-US09075V1026